Deutsch, T. M., Riethdorf, S., Fremd, C., Feißt, M., Nees, J., Fischer, C., . . . Wallwiener, M. (2020). HER2-targeted therapy influences CTC status in metastatic breast cancer. Breast cancer research and treatment, 182(1), . https://doi.org/10.1007/s10549-020-05687-2
Chicago Style (17th ed.) CitationDeutsch, Thomas M., et al. "HER2-targeted Therapy Influences CTC Status in Metastatic Breast Cancer." Breast Cancer Research and Treatment 182, no. 1 (2020). https://doi.org/10.1007/s10549-020-05687-2.
MLA (9th ed.) CitationDeutsch, Thomas M., et al. "HER2-targeted Therapy Influences CTC Status in Metastatic Breast Cancer." Breast Cancer Research and Treatment, vol. 182, no. 1, 2020, https://doi.org/10.1007/s10549-020-05687-2.
Warning: These citations may not always be 100% accurate.